Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
According to Biogen's latest financial reports the company's total liabilities are โน944.58 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | โน972.24 B | -3.04% |
2023-12-31 | โน1.002 T | 8.53% |
2022-12-31 | โน923.96 B | -3.9% |
2021-12-31 | โน961.47 B | -5.64% |
2020-12-31 | โน1.018 T | 2.83% |
2019-12-31 | โน990.88 B | 15.61% |
2018-12-31 | โน857.06 B | 21.42% |
2017-12-31 | โน705.83 B | -3.36% |
2016-12-31 | โน730.39 B | 8.5% |
2015-12-31 | โน673.18 B | 203.42% |
2014-12-31 | โน221.86 B | 10.76% |
2013-12-31 | โน200.32 B | 15.55% |
2012-12-31 | โน173.36 B | 24.96% |
2011-12-31 | โน138.73 B | 17.14% |
2010-12-31 | โน118.43 B | 11.46% |
2009-12-31 | โน106.25 B | -16.42% |
2008-12-31 | โน127.13 B | 4.68% |
2007-12-31 | โน121.44 B | 95.44% |
2006-12-31 | โน62.14 B | -6.43% |
2005-12-31 | โน66.41 B | -34.45% |
2004-12-31 | โน101.31 B | -9.2% |
2003-12-31 | โน111.57 B | 144.92% |
2002-12-31 | โน45.55 B | 153.66% |
2001-12-31 | โน17.95 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | โน7.105 T | 652.28% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | โน3.192 T | 237.93% | ๐บ๐ธ USA |
![]() AbbVie ABBV | โน11.510 T | 1,118.55% | ๐บ๐ธ USA |
![]() Pfizer PFE | โน10.030 T | 961.94% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | โน9.874 T | 945.39% | ๐บ๐ธ USA |
![]() Acorda Therapeutics
ACOR | โน22.84 B | -97.58% | ๐บ๐ธ USA |
![]() Sanofi SNY | โน5.313 T | 462.49% | ๐ซ๐ท France |
![]() Bio-Rad Laboratories BIO | โน243.31 B | -74.24% | ๐บ๐ธ USA |
![]() Illumina ILMN | โน325.90 B | -65.50% | ๐บ๐ธ USA |
![]() Qiagen QGEN | โน182.64 B | -80.66% | ๐ณ๐ฑ Netherlands |